Intranasal immunisation with a 62 kDa proteinase combined with cholera toxin or CpG adjuvant protects against Trichomonas vaginalis genital tract infections in mice

International Journal for Parasitology

Volumn 35, Issue 13, 2005, Pages 1333-1337

  Hernández, Hilda M ^a   Figueredo, Mabel ^a   Garrido, Nidia ^a   Sánchez, Lizet ^a   Sarracent, Jorge ^a  

^a INSTITUTO DE MEDICINA TROPICAL PEDRO KOURÍ   (Cuba)

Author keywords

Adjuvant; Protection; Proteinase; Trichomonas vaginalis

Indexed keywords

CHOLERA TOXIN; CPG OLIGODEOXYNUCLEOTIDE; CYSTEINE PROTEINASE; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; OLIGODEOXYNUCLEOTIDE DERIVATIVE; UNCLASSIFIED DRUG;

SEXUALLY TRANSMITTED DISEASE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; FEMALE; GENITAL TRACT INFECTION; IMMUNIZATION; MOUSE; MOUSE STRAIN; NONHUMAN; PARASITE; TRICHOMONAS VAGINALIS; TRICHOMONIASIS; VAGINAL LAVAGE;

ADJUVANTS, IMMUNOLOGIC; ADMINISTRATION, INTRANASAL; ANIMALS; ANTIBODIES, PROTOZOAN; ANTIGENS, PROTOZOAN; CHOLERA TOXIN; FEMALE; IMMUNIZATION; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; MICE; MICE, INBRED BALB C; OLIGODEOXYRIBONUCLEOTIDES; PEPTIDE HYDROLASES; PROTOZOAN VACCINES; TRICHOMONAS VAGINALIS; TRICHOMONAS VAGINITIS; VAGINA;

PROTOZOA; TRICHOMONAS VAGINALIS;

EID: 26944468279     PISSN: 00207519     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijpara.2005.08.010     Document Type: Article

References (19)

1. M.C. Abraham, M. Desjardins, L.G. Filion, and G.E. Garber Inducible immunity to Trichomonas vaginalis in a mouse model of vaginal infection Infect. Immun. 64 1996 3571 3575
2. J.P. Dalton, P.J. Brindley, D.P. Knox, C.P. Brady, P.J. Hotez, S. Donnelly, S.M. O'Neill, G. Mulcahy, and A. Loukas Helminth vaccines: from mining genomic information for vaccine targets to systems used for protein expression Int. J. Parasitol. 33 2003 621 640
3. R.L. Dunne, L.A. Dunn, P. Upcroft, P.J. O'Donoghue, and J.A. Upcroft Drug resistance in the sexually transmitted protozoan Trichomonas vaginalis Cell. Research. 13 2003 239 240
4. G.E. Garber, and L.T. Lemchuk-Favel Characterization and purification of extracellular proteases of Trichomonas vaginalis Can. J. Microbiol. 35 1989 903 909
5. H. Hernández, I. Sariego, G. Garber, D. Relgado, O. López, and J. Sarracent Monoclonal antibodies against a 62 kDa proteinase of Trichomonas vaginalis decrease parasite cytoadherence to epithelial cells and confer protection in mice Parasite. Immunol. 26 2004 119 125
6. J. Holmgren, J. Adamsson, F. Anjuerec, J. Clemens, C. Czerkinsky, K. Eriksson, C.F. Flach, A. George-Chandy, A.M. Harandi, M. Lebens, T. Lehner, M. Lindblad, E. Nygren, S. Raghavan, J. Sánchez, M. Stanford, J.B. Sun, A.M. Svennerholm, and S. Tengvall Mucosal adjuvants and anti-infection and anti-immunopathology vaccines based on cholera toxin, cholera toxin B subunit and CpG DNA Immunol. Letters 97 2005 181 188
7. J. Holmgren, and C. Czerkinsky Mucosal Immun. vaccines 11 2005 S45 S53
8. R.R. Hook Jr, M.C. St Claire, L.K. Riley, C.L. Franklin, and C.L. Besch-Williford Tritrichomonas foetus: Comparison of isolated virulence in an estrogenized mouse model Exp. Parasitol. 81 1995 202 207
9. A.A. Horner, and E. Raz Immunostimulatory-sequence oligodeoxynucleotide: a novel mucosal adyuvant Clin. Immunol. 95 2000 S19 S29
10. M. Isaka, Y. Yasuda, M. Mizokami, S. Kozuka, T. Taniguchi, K. Matano, J. Maeyama, K. Mizuno, K. Morokuma, K. Ohkuma, N. Goto, and K. Tochikubo Mucosal immunization against hepatitis B virus by intranasal co-administration of recombinant hepatitis B surface antigen and recombinant cholera toxin B subunit as an adjuvant Vaccine 19 2001 1460 1466
11. M. Klemba, and D.E. Goldberg Biological roles of proteinases in parasitic protozoa Ann. Rev. Biochem. 71 2002 275 305
12. W.B. Lushbaugh, A.C. Blossom, P.H. Shah, A.K. Banga, J.M. Jaynes, J.D. Cleary, and R.W. Finley Use of intravaginal microbicides to prevent acquisition of Trichomonas vaginalis infection in Lactobacillus-pretreated, estrogenized young mice Am. J. Trop. Med. Hyg. 63 2000 284 289
13. M.J. McCluskie, and H.L. Davis CpG DNA as mucosal adjuvant Vaccine 18 1999 231 237
14. M.J. McCluskie, R.D. Weeratna, P.J. Payatte, and H.L. Davis The potential of CpG oligodeoxynucleotides as mucosal adjuvants Crit. Rev. Immunol. 21 2001 103 120
15. N. Mielcarek, I. Nordström, F.D. Menozzi, C. Locht, and J. Holmgren Genital antibody responses in mice after intranasal infection with an attenuated candidate vector strain of Bordetella pertussis Infect. Immun. 68 2000 485 491
16. K.G.J. Pollock, K.S. McNeil, J.C. Mottram, R.E. Lyons, J.M. Brewer, P. Scott, G.H. Coombs, and J. Alexander The Leishmania mexicana cysteine protease, CPB2.8, induces potent Th2 responses J. Immunol. 170 2003 1746 1753
17. A.R. Schnapp, C.S. Eickhoff, D. Sizemore, R. Curtiss III, and D.F. Hoft Cruzipain induces both mucosal and systemic protection against Tripanosoma cruzi in mice Infect. Immun. 70 2002 5065 5074
18. J.R. Schwebke, and D. Burgess Trichomoniasis Clin. Microbiol. Rev. 17 2004 794 803
19. D. Soper Trichomoniasis; Under control or undercontrolled Am. J. Obstet. Gynecol. 190 2004 281 290